重金属的表观遗传毒性 - 对胚胎干细胞的影响
Nicholas Kim1, David Filipovic2, Sudin Bhattacharya3
1Division of Environmental Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10010, USA.
Environment international
|October 22, 2024
概括
重金属通过改变它们的表观基因组来破坏干细胞的发育,影响DNA甲基化和基因素修饰. 本综述详细介绍了有毒金属如何影响干细胞的功能和分化.
科学领域:
- 毒理学 毒理学 毒理学
- 发展生物学 发展生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 重金属 (如,,) 与发育异常有关.
- 干细胞和祖细胞对表观遗传变化敏感.
- 这些细胞依赖于表观遗传重编程才能正常运作.
研究的目的:
- 审查重金属对干细胞的表观遗传影响.
- 专注于DNA甲基化和基因素修饰.
- 探索这些表观遗传变化背后的机制.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 关注重金属暴露和干细胞的证据.
- 对表观遗传修饰的分析 (DNA甲基化,基因素修饰).
主要成果:
- 重金属是强大的表观遗传修饰剂.
- 暴露可以损害干细胞的增殖,多能性和分化.
- 特定的金属如,,,,,,和六价都与此有关.
结论:
- 暴露于重金属会诱导干细胞的表观遗传变化.
- 这些变化会扰乱干细胞的正常功能和发育.
- 了解这些机制对于毒理学和发育生物学研究至关重要.
相关概念视频
Embryonic Stem Cells
3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K
The Periodic Table and Organismal Elements
176.8K
Overview
176.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


